drugset / Trial / NCT00369863

A Randomized, Placebo-Controlled Clinical Trial of Intravitreal Triamcinolone for Refractory Diabetic Macular Edema

NCT00369863

Phase 2 Completed 76 enrolled Shahid Beheshti University of Medical Sciences
RandomizedParallel-groupSingle-blindTreatment

Summary

To determine the efficacy and safety of intravitreal triamcinolone acetonide for refractory diabetic macular edema.

Timeline

Start
2002-06
Primary completion
Completion
2003-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Triamcinolone Acetonide Other / unclassified Intravitreal